Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for insulin resistance in type 2 diabetes mellitus
NCT02601989Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Nov 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in type 2 diabetes mellitus (T2DM), sponsored by University of Gothenburg. Started Nov 2015; status: completed.
02
Drugs
tadalafil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02601989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601989.